You are here: Home » PTI Stories » National » News
Business Standard

Alembic Pharma shares up over 3 pc on USFDA nod for antibiotic capsules

Press Trust of India  |  New Delhi 

Shares of today rose by over 3 per cent after the company received approval from the US health regulator for its Hyclate capsules used for the treatment of a wide variety of

The stock went up by 3.32 per cent to settle at Rs 506.55 on the During the day, it surged 8 per cent to Rs 529.90.

On the NSE, shares of the company went up by 2.64 per cent to close at Rs 504.85.

The approval from the Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Hyclate capsules USP, in the strengths of 50 mg and 100 mg, said in a filing.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, June 14 2018. 18:00 IST